BXPHF (Botanix Pharmaceuticals) Quick Ratio: 1.56 (As of Dec. 2025) — 79% Below Median


What is Botanix Pharmaceuticals Quick Ratio?

Botanix Pharmaceuticals BXPHF Quick Ratio is 1.56 as of Dec. 2025, which is 79% below its 10-year median of 7.56. The stock has 7 warning signs investors should review. Among 1,410 Biotechnology companies, Botanix Pharmaceuticals ranks worse than 71.77% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Botanix Pharmaceuticals's quick ratio for the quarter that ended in Dec. 2025 was 1.56.

Botanix Pharmaceuticals has a quick ratio of 1.56. It generally indicates good short-term financial strength.

The historical rank and industry rank for Botanix Pharmaceuticals's Quick Ratio or its related term are showing as below:

BXPHF' s Quick Ratio Range Over the Past 10 Years
Min: 1.05   Med: 7.56   Max: 21.89
Current: 1.56

During the past 13 years, Botanix Pharmaceuticals's highest Quick Ratio was 21.89. The lowest was 1.05. And the median was 7.56.

BXPHF's Quick Ratio is ranked worse than
71.77% of 1410 companies
in the Biotechnology industry
Industry Median: 3.6 vs BXPHF: 1.56

Botanix Pharmaceuticals  (OTCPK:BXPHF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Botanix Pharmaceuticals Quick Ratio Related Terms


Botanix Pharmaceuticals Quick Ratio Historical Data

* Premium members only.

The historical data trend for Botanix Pharmaceuticals's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Botanix Pharmaceuticals Quick Ratio Chart

Botanix Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.81 1.09 5.75 21.89 2.87

Botanix Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.14 21.89 7.96 2.87 1.56

BXPHF vs VRTX, REGN, ALNY: Quick Ratio Comparison

For the Biotechnology subindustry, Botanix Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Botanix Pharmaceuticals Quick Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Botanix Pharmaceuticals's Quick Ratio falls into.



Botanix Pharmaceuticals Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Botanix Pharmaceuticals's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Quick Ratio (A: Jun. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(64.835-18.279)/16.225
=2.87

Botanix Pharmaceuticals's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(47.003-18.28)/18.381
=1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.56 mean?
Botanix Pharmaceuticals (BXPHF) has a Quick Ratio of 1.56 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Botanix Pharmaceuticals and its competitors. This is 79% below median its historical median of 7.56. Over the past decade, Botanix Pharmaceuticals' Quick Ratio has ranged from 1.05 to 21.89. According to the industry distribution chart, Botanix Pharmaceuticals ranks #1012 out of 1410 companies in the Biotechnology industry, placing it in the top 71.8%.
Is Botanix Pharmaceuticals' Quick Ratio too high?
Botanix Pharmaceuticals' current Quick Ratio of 1.56 is 79% below median its 10-year median of 7.56. Over the past 10 years, this metric has ranged from a low of 1.05 to a high of 21.89. The Biotechnology industry median Quick Ratio is 3.60. Botanix Pharmaceuticals' value of 1.56 is 56.7% below this industry median. Based on the distribution chart, Botanix Pharmaceuticals ranks #1012 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint.
How does Botanix Pharmaceuticals' Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Botanix Pharmaceuticals ranks #1012 out of 1410 companies for Quick Ratio. This places Botanix Pharmaceuticals in the lower half of its industry. The industry median Quick Ratio is 3.60. Botanix Pharmaceuticals' value of 1.56 is 56.7% below this benchmark. Historically, Botanix Pharmaceuticals' own Quick Ratio has ranged from 1.05 to 21.89 over the past decade. While the company's 10-year median is 7.56 vs. the industry median of 3.60, Botanix Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Botanix Pharmaceuticals's current Quick Ratio of 1.56 is 56.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Botanix Pharmaceuticals and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Botanix Pharmaceuticals's current Quick Ratio is 1.56, which is 79% below median its own 10-year median of 7.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Botanix Pharmaceuticals stock overvalued right now?
Botanix Pharmaceuticals (BXPHF) has a current Quick Ratio of 1.56. The current Quick Ratio is 1.56, which is 79% below median its 10-year median of 7.56 and 56.7% below the Biotechnology industry median of 3.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Botanix Pharmaceuticals (BXPHF), the current Quick Ratio is 1.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Botanix Pharmaceuticals Business Description

Other Exchanges BOT:Australia
Address 41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.